Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorDavid M. Ritter
About this trial
This study is an observational registry designed to gather information about Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) in pregnant women and their child.
Eligibility criteria
Qualifiers
A pregnant woman with a clinical or genetic diagnosis of TSC as determined by the 2021 Consensus Guidelines (1)
A pregnant woman with a diagnosis of LAM
A pregnant woman with a variant of uncertain significance in TSC 1 or TSC 2
A pregnant woman who is pregnant and the fetus has a 50% chance of TSC as deemed by the PI or Sub-Is
Disqualifiers
A pregnant woman without TSC who has used preimplantation genetic testing for TSC unless qualifies under inclusion criteria #4.
Infants diagnosed with TSC whose birth mother was not enrolled.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
David M. Ritter
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Sponsor institution
Source ClinicalTrials.gov